Decisión del Panel Administrativo nº D2020-1581 of WIPO Arbitration and Mediation Center, September 21, 2020 (case Pfizer Inc. v. Contact Privacy Inc. Customer 1247423951 / Name Redacted)

• Resolution Date: September 21, 2020
• Issuing Organization: WIPO Arbitration and Mediation Center
• Decision: Transfer
• Dominio: Generic Domains

WIPO Arbitration and Mediation Center

ADMINISTRATIVE PANEL DECISION

Pfizer Inc. v. Contact Privacy Inc. Customer 1247423951 / Name Redacted

Case No. D2020-1581

1. The Parties

Complainant is Pfizer Inc., United States of America (“United States”), represented by Arnold & Porter Kaye Scholer LLP, United States.

Respondent is Contact Privacy Inc. Customer 1247423951, Canada / Name Redacted[1 ].

2. The Domain Name and Registrar

The disputed domain name [plfizer.com] is registered with Google LLC (the “Registrar”).

3. Procedural History

The Complaint was filed with the WIPO Arbitration and Mediation Center (the “Center”) on June 16, 2020. On June 17, 2020, the Center transmitted by email to the Registrar a request for registrar verification in connection with the disputed domain name. On June 17, 2020, the Registrar transmitted by email to the Center its verification response disclosing registrant and contact information for the disputed domain name which differed from the named Respondent and contact information in the Complaint. The Center sent an email communication to Complainant on June 23, 2020 providing the registrant and contact information disclosed by the Registrar, and inviting Complainant to submit an amendment to the Complaint. Complainant filed an amended Complaint on June 24, 2020.

The Center verified that the Complaint together with the amended Complaint satisfied the formal requirements of the Uniform Domain Name Dispute Resolution Policy (the “Policy” or “UDRP”), the Rules for Uniform Domain Name Dispute Resolution Policy (the “Rules”), and the WIPO Supplemental Rules for Uniform Domain Name Dispute Resolution Policy (the “Supplemental Rules”).

In accordance with the Rules, paragraphs 2 and 4, the Center formally notified Respondent of the Complaint, and the proceedings commenced on July 10, 2020. In accordance with the Rules, paragraph 5, the due date for Response was July 30, 2020. On July 15, 2020, July 17, 2020, and July 22, 2020, the Center received email communications from [Name Redacted] regarding identification of Respondent. Complainant submitted a settlement form signed by Complainant and [Name Redacted]. Accordingly, in order to proceed with the settlement process, as provided in the Rules, paragraph 17, the Center requested confirmation regarding an intention to settle from the registrant of the disputed domain name by means of the Registrar-confirmed email address. Respondent did not submit any response. Accordingly, the Center notified the Parties that it would proceed to panel appointment on August 24, 2020.

The Center appointed Brian J. Winterfeldt as the sole panelist in this matter on September 7, 2020. The Panel finds that it was properly constituted. The Panel has submitted the Statement of Acceptance and Declaration of Impartiality and Independence, as required by the Center to ensure compliance with the Rules, paragraph 7.

4. Factual Background

Complainant is one of the largest pharmaceutical manufacturers and sellers in the world, maintaining global operations in more than 125 countries. Complainant has used the PFIZER trademark (“PFIZER Mark” or “Complainant’s Mark”) in connection with pharmaceutical products and consumer healthcare products since 1849. It owns multiple trademark registrations for the PFIZER Mark around the world, including United States registration numbers 626,088 and 5,082,880 (registered on May 1, 1956 and November 15, 2016, respectively). ThePFIZER Mark has been recognized as famous by various other UDRP...